Cloverleaf Bio

Cloverleaf Bio has designed and engineered "trojan horse tRNAs" that can inhibit over 25 tRNA-modifying enzymes, aiming to create highly potent and targeted cancer therapeutics, beginning with hepatocellular carcinoma (HCC). The venture’s innovation enhances therapeutic efficacy in addition to reducing the likelihood o

Operating in advanced therapies, Cloverleaf Bio operates.

Profile

Cloverleaf Bio has designed and engineered "trojan horse tRNAs" that can inhibit over 25 tRNA-modifying enzymes, aiming to create highly potent and targeted cancer therapeutics, beginning with hepatocellular carcinoma (HCC). The venture’s innovation enhances therapeutic efficacy in addition to reducing the likelihood of resistance, which is currently commonly developed by cancer patients within 1-2 years […]

As a business in advanced therapies, Cloverleaf Bio is listed here with the public details available about it.

Directory data places it at the Creative Destruction Lab alumni company stage.

Website: cloverleafbio.com